Fabry disease and the skin: data from FOS, the Fabry outcome survey. (Q31116015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Fabry disease and the skin: data from FOS, the Fabry outcome survey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Guillem Pintos-Morell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Rossella Parini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Gere Sunder-Plassmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

C H Orteu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

T Jansen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

O Lidove

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

R Jaussaud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

U Ramaswami

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

M Beck

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

A B Mehta

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

FOS Investigators

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

15 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

331-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

The molecular defect leading to Fabry disease: structure of human alpha-galactosidase

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Cutaneous manifestations of fucosidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Angiokeratoma corporis diffusum associated with beta-mannosidase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fabry disease: recognition and management of cutaneous manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fabry disease: impaired autonomic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Quantitative dysmorphology assessment in Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Treatment of lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fabry disease: overall effects of agalsidase alfa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Natural history of Fabry disease in females in the Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Hearing loss in Fabry disease: data from the Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Prevalence of uncontrolled hypertension in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Lymphoedema: an underestimated health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08002.X

10.1111/J.1365-2133.2007.08002.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17573884%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference